Rezultati

eNauka >  Rezultati >  Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, PlaceboControlled Phase II Study
Naziv: Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, PlaceboControlled Phase II Study
Autori: Hart Lowel L; Ferrarotto Renata; Andrić Zoran G  ; Beck Thaddeus J; Subramanian Janakiraman; Radosavljević Davorin Z  ; Zarić Bojan  ; Hanna Wahid T; Aljumaily Raid; Owonikoko Taofeek K;
Verhoeven Didier; Xiao Jie; Morris Shannon R; Antal Joyce M; Hussein Maen A;
Godina: 2020
Publikacija: ADVANCES IN THERAPY
ISSN: 0741-238X Advances in Therapy Pretraži identifikator
Izdavač: Springer
Tip rezultata: Naučni članak
Kolacija: vol. 38 br. 1 str. 350-365
DOI: 10.1007/s12325-020-01538-0
WoS-ID: 000582826000001
Scopus-ID: 2-s2.0-85094653176
PMID: 33123968
PMCID: PMC7854399
URI: https://zenodo.org/record/4709814
https://enauka.gov.rs/handle/123456789/597482
Projekat: url:https://static-content.springer.com/esm/art%3A10.1007%2Fs12325-020-01538-0/MediaObjects/12325_2020_1538_MOESM3_ESM.docx
pmcid:PMC7854399
doi:10.6084/ m9.figshare.13078844.
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

105
SCOPUSTM
50
PubMed CentralTM
41
OpenCitations
92
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.